We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by... Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -0.827129859388 | 12.09 | 12.15 | 11.2809 | 1506230 | 11.69839733 | CS |
4 | 1.19 | 11.0185185185 | 10.8 | 12.1999 | 10.62 | 1317066 | 11.53297447 | CS |
12 | 2.32 | 23.9917269907 | 9.67 | 12.1999 | 7.33 | 1330280 | 10.03715372 | CS |
26 | -4.38 | -26.7562614539 | 16.37 | 16.69 | 7.33 | 1059487 | 10.54929526 | CS |
52 | -3.19 | -21.0144927536 | 15.18 | 23.22 | 7.33 | 592216 | 11.2956402 | CS |
156 | -14.51 | -54.7547169811 | 26.5 | 26.5 | 7.33 | 390435 | 11.42716495 | CS |
260 | -14.51 | -54.7547169811 | 26.5 | 26.5 | 7.33 | 390435 | 11.42716495 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions